30
Participants
Start Date
January 6, 2026
Primary Completion Date
September 21, 2029
Study Completion Date
December 21, 2029
MDMA Hydrochloride
Initial dose of 120 mg MDMA HCl in a therapeutic setting, followed 1.5 to 2 hours later by a supplemental dose of 40 mg MDMA HCl. Supplemental doses may be withheld if tolerability issues emerge or it is declined by the participant.
The Parsons Research Center for Psychedelic Healing, New York
Rachel Yehuda
OTHER